Deep Track Capital, LP Apellis Pharmaceuticals, Inc. Transaction History
Deep Track Capital, LP
- $3.17 Billion
- Q3 2025
A detailed history of Deep Track Capital, LP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 8,000,382 shares of APLS stock, worth $163 Million. This represents 5.71% of its overall portfolio holdings.
Number of Shares
8,000,382
Previous 7,000,000
14.29%
Holding current value
$163 Million
Previous $121 Million
49.42%
% of portfolio
5.71%
Previous 4.3%
Shares
7 transactions
Others Institutions Holding APLS
# of Institutions
328Shares Held
124MCall Options Held
4.15MPut Options Held
769K-
Avoro Capital Advisors LLC New York, NY12.2MShares$248 Million3.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.99MShares$203 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.64MShares$196 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA9.29MShares$189 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$118 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.23B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...